Valbonne, France

Jean-Guy Boiteaux


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jean-Guy Boiteaux: Innovator in Chemokine-Mediated Treatments

Introduction

Jean-Guy Boiteaux is a notable inventor based in Valbonne, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of chemokine-mediated diseases. With a total of 2 patents to his name, Boiteaux's work is recognized for its innovative approach to medical treatments.

Latest Patents

Boiteaux's latest patents include the development of disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds. These compounds are designed for use in the treatment of chemokine-mediated diseases. The first patent describes pharmaceutical compositions that incorporate these compounds and outlines methods for their application in treating such diseases. The second patent similarly focuses on disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds, emphasizing their use in addressing chemokine-mediated pathologies.

Career Highlights

Jean-Guy Boiteaux is currently associated with Galderma Research & Development, where he continues to innovate in the pharmaceutical sector. His work is pivotal in advancing treatments that target complex medical conditions.

Collaborations

Throughout his career, Boiteaux has collaborated with esteemed colleagues, including Branislav Musicki and Jerôme Aubert. These partnerships have contributed to the success and impact of his research.

Conclusion

Jean-Guy Boiteaux stands out as a key figure in the development of novel treatments for chemokine-mediated diseases. His patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…